Amneal asks FDA to approve another new formulation of Parkinson’s combo drug 

After having already received FDA approval for a carbidopa/levodopa combination in 2015, Amneal Pharmaceuticals is again at the regulator’s doorstep with another new combination of the decades-old Parkinson’s treatment.